Future myasthenia gravis therapies have different mechanisms of action than current treatments, said James F. Howard Jr, MD, professor of neurology at the University of North Carolina at Chapel Hill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback